Prof. Abdulrazaq G. Habib

Abdulrazaq G. Habib, MBBS, MSc Epid [Lond], MRCP (UK), FWACP, FRCP [Lond], FAMS (Infect), FAMedS, FAS

Prof. Habib is an infectious and tropical diseases physician, epidemiologist, public health practitioner and educator. He is a member Royal College of Physicians (UK), fellow Royal College of Physicians (London), fellow of West African College of Physicians, fellow Academy of Medicine Singapore (Infections), fellow Academy of Medical Sciences and fellow Nigerian Academy of Sciences. He trained and worked in institutions across Nigeria, the United Kingdom, and Singapore. He currently and leads or co-leads both the Kano Meningitis Modelling Group and the Nigerian Snakebite Research and Intervention Centre - https://nsric-asrg.org.ng/.

His research interests span several global health priorities, including community-acquired infections, antimicrobial resistance, COVID-19, emerging infectious diseases, HIV infection, immunology, clinical epidemiology, tropical diseases, snakebite envenoming, and health economics. More recently, his work has focused on evaluating the impact of multivalent conjugate meningococcal vaccines in Africa and other conditions of major global health importance.

Recognized among the world’s top 2% scientists in both 2024 and 2025, he had an H-index of 46 as of May 2026. Together with collaborators, he received support from the National Institute for Health and Care Research (NIHR) and the Department for International Development (DfID) for research on snakebite in Africa, and is currently supported by the Vaccine Impact Modelling Consortium.

He has served in advisory, leadership, trustee, and membership capacities for several national and international bodies, including the Society of HIV Care Clinicians in Nigeria, Toxinology Society of Nigeria, Technical Advisory Group on Noma, Ministerial Taskforce on COVID-19, Nigerian Immunization Technical Advisory Group, National Adverse Events Following Immunization Committee, Global Snakebite Initiative, and the WHO Strategic Advisory Group of Experts workgroup on meningococcal meningitis vaccines in Geneva. He was also the founding president of the Nigerian Infectious Diseases Society and pioneer chair of the International Society on Toxinology Africa & Middle East Section.

He has participated in six clinical trials and served as Nigeria’s national principal investigator for the WHO-sponsored Solidarity Plus Clinical Trial involving hospitalized COVID-19 patients across nine sites in Nigeria. In addition, he has supported several global health initiatives, including the Institute of Human Virology Nigeria PEPFAR program, and currently works as a consultant on the “Integrated Child Survival Advocacy at the Last Mile” project implemented across five northern Nigerian states with support from the Gates Foundation.

He previously served as Head of the Department of Medicine, Dean of the Faculty of Medicine, and later founding Provost, College of Health Sciences at Bayero University Kano, while also working as a consultant physician at Aminu Kano Teaching Hospital, Kano, Nigeria. He remains actively engaged in undergraduate and postgraduate teaching, supervision, mentorship, research, and clinical practice.